NATIONAL FRAGILE X FOUNDATION

Lobbying Spend

—

Filings

Firms Hired

Active Period

2003–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	6	2
2025	—	7	2
2024	—	6	2
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	5	1
2010	—	4	1
2009	—	8	1
2008	—	4	1
2007	—	2	1
2006	—	2	1
2005	—	1	1
2004	—	1	1
2003	—	2	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
FAEGRE BAKER DANIELS CONSULTING	—	24
WATKINS & EAGER PLLC	—	21
HARPER & BAILEY GOVERNMENTAL SOLUTIONS LLC	—	9
WINNING STRATEGIES WASHINGTON	—	6

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	56
SENATE	56
Natl Institutes of Health (NIH)	23
Centers For Disease Control & Prevention (CDC)	16

Most frequently reported lobbying issues

Issue Code	Description	Reports
Government Issues	Government Issues	53
Health Issues	Health Issues	31
Education	Education	20
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	20
Budget/Appropriations	Budget/Appropriations	3

NATIONAL FRAGILE X FOUNDATION — Lobbying Disclosure | Poliscope